Cagrilintide 5mg
概要
Cagrilintide 5mg is a next-generation long-acting amylin analogue research peptide designed for advanced metabolic, obesity, and appetite-regulation studies.
As an amylin-based peptide, Cagrilintide targets one of the most important hormonal pathways involved in satiety signaling, gastric emptying, food-intake regulation, and body-weight research. Unlike GLP-1 receptor agonists, which primarily focus on incretin signaling, Cagrilintide provides researchers with a complementary mechanism centered on the amylin pathway.
This makes Cagrilintide a valuable research compound for studying appetite suppression, energy-balance modulation, metabolic adaptation, and body-composition changes. It has also gained significant attention in combination research models involving GLP-1 analogues such as semaglutide, where amylin and incretin pathways may be studied together for broader metabolic effects.
Each vial contains 5mg of high-purity lyophilized Cagrilintide, produced under controlled conditions and verified by third-party Janoshik laboratory analysis to confirm molecular identity and peptide purity. This product is provided strictly for research use only and is not approved for human or veterinary applications.
科学的背景
Cagrilintide was developed as a long-acting analogue of amylin, a pancreatic peptide hormone co-secreted with insulin by beta cells. Native amylin plays an important physiological role in regulating satiety, slowing gastric emptying, reducing post-meal glucagon secretion, and supporting glucose-metabolism balance.
However, native human amylin has poor stability and a tendency toward aggregation, limiting its practical research use. Cagrilintide was engineered to improve stability, extend duration of action, and reduce aggregation tendency, making it more suitable for long-acting metabolic research models.
Its mechanism of interest is primarily linked to amylin-receptor pathway activation, which may help researchers investigate:
Appetite and satiety signaling through central nervous system pathways.
Delayed gastric emptying and reduced food-intake models.
Body-weight and fat-mass reduction research.
Glucose and glucagon regulation in metabolic studies.
Combination models with GLP-1 receptor agonists.
Compared with single-pathway incretin peptides, Cagrilintide allows researchers to explore a distinct but complementary metabolic mechanism. This has positioned it as an important research peptide in the expanding field of next-generation obesity and metabolic-disease investigation.
Cagrilintide is especially relevant for studies focused on:
Weight-management research, particularly food-intake and appetite-control models.
Amylin-pathway signaling, including receptor activation and downstream metabolic response.
Combination peptide research, especially with GLP-1 analogues.
Energy-balance studies, including satiety, caloric intake, and body-composition models.
Metabolic syndrome research, including glucose regulation and hormonal cross-talk.
主な利点
Long-acting amylin analogue – designed for sustained metabolic research activity.
Distinct mechanism from GLP-1 peptides – supports appetite and gastric-emptying studies through the amylin pathway.
Ideal for combination research – commonly studied alongside GLP-1 analogues such as semaglutide.
High-purity peptide – verified by third-party analytical testing.
Stable lyophilized format – optimized for laboratory storage and handling.
Suitable for obesity, appetite-regulation, and metabolic research models.
包装と品質管理
Each vial of Cagrilintide 5mg is filled and sealed under controlled conditions using high-quality sterile glass vials to help preserve peptide stability.
Every production batch is supported by analytical documentation, including Certificate of Analysis data and third-party laboratory testing where applicable. HPLC analysis is used to assess peptide purity, while mass spectrometry is used to confirm molecular identity and sequence accuracy.
Our Cagrilintide 5mg is maintained under temperature-controlled storage conditions and prepared for reliable shipment to qualified research laboratories, institutions, and distributors.
保管と取り扱い
Store unopened vials at −20 °C in a dry, dark environment.
After reconstitution, store between 2–8 °C and use within a short research window.
繰り返される凍結融解のサイクルは避けてください。
Use sterile laboratory technique when reconstituting.
For laboratory research only; not for human or veterinary administration.
SEOメタ説明
Cagrilintide 5mg is a high-purity long-acting amylin analogue research peptide for appetite, metabolic, obesity, and body-weight studies. Third-party tested; supplied in lyophilized vial format for research use only.
SEO Keywords
Cagrilintide 5mg, Cagrilintide peptide, Cagrilintide research peptide, amylin analogue peptide, long-acting amylin analogue, appetite-regulation peptide, obesity research peptide, weight-management research peptide, metabolic research peptide, body-weight research compound, amylin receptor research, GLP-1 combination research, Cagrilintide semaglutide research, peptide for metabolic studies, lyophilized Cagrilintide, Janoshik-tested peptide, research use only peptide
